Havens Advisors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Havens Advisors’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-100,000	Closed	-$1.79M	–	36
2017 Q4	$1.79M	Buy	+100,000	New	+$1.23M	1.35%	18

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Havens Advisors's SCMP Position: Q1 2018 in Review

Havens Advisors sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 100,000 shares — an estimated $1.79M sold.

Havens Advisors first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $1.79M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Havens Advisors reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Havens Advisors sold 100,000 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.79M.
Havens Advisors first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
Havens Advisors's Sucampo Pharmaceuticals, Inc. position peaked at $1.79M in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Havens Advisors's 13F filing for Q1 2018, filed 17 Apr 2018.